Riskpilot← Back to searchSign inGet full accessMedikardio Oy
OYDissolvedY-tunnus 3256582-3Lindforsinkatu 8-C44General medical practice activities · NACE 8621Est. 2021— employees
Revenue 2025
EUR 568K
+36% vs 2024
EBITDA margin
57.5%
+111% vs 2024
Equity ratio
76.8%
Financial strength
Net profit 2025
EUR 251K
+130% vs 2024
| Revenue | EUR 568K | +36% |
| EBITDA | EUR 327K | +111% |
| Net profit | EUR 251K | +130% |
| Total assets | EUR 581K | +52% |
| Equity | EUR 446K | +144% |
| Employees | — | — |
Legal name
Medikardio Oy
Y-tunnus number
3256582-3
Legal form
Osakeyhtiö
NACE code
8621 · General medical practice activities
Founded
24. joulukuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
86210 Terveyskeskus- ja vastaavat yleislääkäripalvelut
Address
Lindforsinkatu 8-C44
Phone
+3580405955935
Email
info.medikardio@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 105 | 185 | 419 | 568 |
| Staff expenses | −12 | −103 | −171 | −65 |
| EBITDA | 82 | 69 | 155 | 327 |
| Depreciation & amort. | −7 | −24 | −18 | −12 |
| EBIT | 75 | 45 | 137 | 315 |
| Net financials | −0 | −1 | −1 | −1 |
| Profit before tax | 75 | 44 | 137 | 314 |
| Tax | 15 | 9 | 27 | 63 |
| Net profit | 60 | 35 | 109 | 251 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 108 | 193 | 381 | 581 |
| Equity | 60 | 90 | 182 | 446 |
| Long-term debt | — | 9 | 0 | 0 |
| Short-term debt | 48 | 103 | 199 | 135 |
| Total debt | 48 | 103 | 199 | 135 |
EBITDA margin
57.5%
This company
15.8%
Market median
+264% vs market
20222025
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
20222025
Return on equity
56.2%
This company
18.4%
Market median
+205% vs market
20222025
Net profit margin
44.1%
This company
8.1%
Market median
+444% vs market
20222025
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20222025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
ZS Deputy Member | Deputy Member | 2022 |
AS Chief Executive Officer | Chief Executive Officer | 2022 |
SM | Audit | 2026 |
AJ Deputy auditor | Deputy auditor | 2026 |
IS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medikardio Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Zarghona Shuaibi | Deputy Member | 0 companies |
| Atiqullah Shuaibi | Chief Executive Officer | 0 companies |
| Sami Mikael Koivistoinen | Audit | 0 companies |
| Arto Juhani Saarinen | Deputy auditor | 0 companies |
| Inayatullah Shuaibi | Deputy Chief Executive Officer | 0 companies |